Viridian Therapeutics, Inc. (VRDN)

Market price: $24.09

1 valuation method

• P / B: $17.54 to $60.09 (midpoint $27.36)

Pre-profit company — earnings-based methods not meaningful.

Limited data — fewer than three valuation methods could be formed for this company; showing every method we can stand behind.